Detalhe da pesquisa
1.
Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling.
Hum Mol Genet
; 26(21): 4301-4313, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28973304
2.
Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture.
Am J Hum Genet
; 97(6): 816-36, 2015 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26626624
3.
Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes.
Am J Hum Genet
; 95(2): 162-72, 2014 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25087609
4.
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.
J Am Acad Dermatol
; 76(2): 290-298, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27908543
5.
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
Am J Hum Genet
; 90(5): 796-808, 2012 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22521419
6.
Essential Truths for the Care and Management of Moderate-to-Severe Psoriasis.
J Drugs Dermatol
; 14(8): 805-12, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26267724
7.
Impact of pigmentary disorders on quality of life in Japan: Interest of the BeautyQoL instrument.
J Cosmet Laser Ther
; 17(6): 313-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25968164
8.
Clinical efficacy, radiographic and safety findings through 5â years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study).
Ann Rheum Dis
; 73(9): 1689-94, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24748630
9.
Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.
J Am Acad Dermatol
; 71(4): 633-41, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24928705
10.
Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis.
J Am Acad Dermatol
; 71(4): 623-32, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24894455
11.
Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.
J Am Acad Dermatol
; 71(6): 1167-75, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25260564
12.
Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): experience with infliximab and other systemic and biologic therapies.
J Drugs Dermatol
; 13(12): 1441-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25607786
13.
PAPRIKA: A Question Bank for Assessing Psoriatic Arthritis Risk in Individuals of Diverse Ancestries.
Arthritis Care Res (Hoboken)
; 76(3): 421-425, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691268
14.
Measuring Psoriasis Severity at Home.
J Vis Exp
; (205)2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497631
15.
Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab.
Ann Rheum Dis
; 72(1): 83-8, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22975755
16.
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study.
Ann Rheum Dis
; 72(11): 1777-85, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23161902
17.
Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.
J Am Acad Dermatol
; 69(6): 931-7, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24054760
18.
Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.
J Am Acad Dermatol
; 68(2): 262-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22910105
19.
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.
J Am Acad Dermatol
; 68(1): 64-72, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22846688
20.
Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial.
Arthritis Rheum
; 64(8): 2504-17, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22378566